The session will discuss the implications of overdiagnosis and overtreatment in prostate cancer management, with a focus on how biopsy regimens contribute to these challenges. It will review the indications, adoption, and risk assessment in active surveillance in North America and Europe and discuss differences. Additionally, the session aims to describe the scenarios for abbreviated prostate MRI and discuss the pros and cons of contrast-enhanced imaging and how the omission of MR sequences may impact the diagnostic accuracy.
Chairpersons' introduction
Tristan Barrett, Cambridge / United Kingdom
Andrei Saraiva Purysko, Cleveland / United States
Impact of biopsy strategies in early detection and active surveillance in US
Andrei Saraiva Purysko, Cleveland / United States
Active surveillance in Europe and how indications/definitions may differ between US and Europe
Tristan Barrett, Cambridge / United Kingdom
Contrast-enhanced imaging and indications for abbreviated prostate MRI: pros and cons
Patrick Asbach, Berlin / Germany